Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells ; volume:130 ; number:8 ; day:4 ; month:4 ; year:2024 ; pages:1414 ; date:5.2024
British journal of cancer ; 130, Heft 8 (4.4.2024), 1414, 5.2024

Creator
Rio-Vilariño, Anxo
Cenigaonandia-Campillo, Aiora
García-Bautista, Ana
Mateos-Gómez, Pedro A.
Schlaepfer, Marina I.
Puerto-Nevado, Laura del
Aguilera, Oscar
García-García, Laura
Galeano, Carlos
Miguel, Irene de
Serrano-López, Juana
Baños, Natalia
Fernández-Aceñero, María Jesús
Lacal, Juan Carlos
Medico, Enzo
García-Foncillas, Jesús
Cebrián, Arancha
Contributor
SpringerLink (Online service)

DOI
10.1038/s41416-024-02667-x
URN
urn:nbn:de:101:1-2406252121071.663148890188
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Rio-Vilariño, Anxo
  • Cenigaonandia-Campillo, Aiora
  • García-Bautista, Ana
  • Mateos-Gómez, Pedro A.
  • Schlaepfer, Marina I.
  • Puerto-Nevado, Laura del
  • Aguilera, Oscar
  • García-García, Laura
  • Galeano, Carlos
  • Miguel, Irene de
  • Serrano-López, Juana
  • Baños, Natalia
  • Fernández-Aceñero, María Jesús
  • Lacal, Juan Carlos
  • Medico, Enzo
  • García-Foncillas, Jesús
  • Cebrián, Arancha
  • SpringerLink (Online service)

Other Objects (12)

Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy

Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy

Oligonucleotides—A Novel Promising Therapeutic Option for IBD

Oligonucleotides—A Novel Promising Therapeutic Option for IBD

Ghrelin as a Promising Therapeutic Option for Cancer Cachexia

Ghrelin as a Promising Therapeutic Option for Cancer Cachexia

Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors

Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors

Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?

Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy

Cell-Free Protein Synthesis: A Promising Option for Future Drug Development

Cell-Free Protein Synthesis: A Promising Option for Future Drug Development

Cetuximab Induces Eme1-Mediated DNA Repair: a Novel Mechanism for Cetuximab Resistance

Cetuximab Induces Eme1-Mediated DNA Repair: a Novel Mechanism for Cetuximab Resistance

Requirement for YAP1 signaling in myxoid liposarcoma

Requirement for YAP1 signaling in myxoid liposarcoma

YAP1-fusions in pediatric NF2-wildtype meningioma

YAP1-fusions in pediatric NF2-wildtype meningioma

The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1

The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1

Related objects